Moreover, ETAR gene silencing contributed to alleviating myocardial inflammation, while ETBR gene silencing exacerbated myocardial inflammation, suggesting that ETAR and ETBR can be regarded as novel biomarkers to characterize heart failure induced by EAM. This evidence concerns the gene EDNRB and heart failure.